Gallstone Risk in Adult Patients with Atopic Dermatitis and Psoriasis: Possible Effect of Overweight and Obesity.

This study investigated the prevalence and risk of gallstones in adults with AD and in those with psoriasis as a proxy for obesity using nationwide data for all Danish citizens ≥ 30 years of age. Outcome was a diagnosis of gallstones. Odds ratios (ORs) were calculated by logistic regression (cross-sectional study) and hazard ratios (HRs) were estimated by Cox regression (cohort study). The study comprised 6,742 patients with AD, 53,810 patients with psoriasis, and 3,534,164 general population subjects. The prevalence of gallstones was 3.8%, 3.5% and 5.0% in the general population, AD and psoriasis patients, respectively. Adjusted ORs were 0.81 (0.71-0.92) for AD and 1.18 (1.14-1.23) for psoriasis. During follow-up, adjusted HRs were 0.72 (0.56-0.90) for AD and 1.10 (1.02-1.18) for psoriasis. The findings highlight important differences in obesity and lifestyle factors among patients with AD and those with psoriasis. PMID: 28119993 [PubMed - as supplied by publisher]
Source: Acta Dermato-Venereologica - Category: Dermatology Authors: Tags: Acta Derm Venereol Source Type: research

Related Links:

Publication date: December 2019Source: Journal of Transport &Health, Volume 15Author(s): Lake Sagaris, Daniel LanfrancoAbstractAn abundant literature has examined the usefulness of “safe routes to school” programs to increase active transport (mainly walking and cycling) and with it levels of physical activity, hence health. To date, these have been applied mainly in the Global North, where they are supported by national networks and government.Conditions in developing countries differ. While the obesity epidemic is rife, the sustainability trio of walk-bike-bus/Metro account for high percentages (66% or mo...
Source: Journal of Transport and Health - Category: Occupational Health Source Type: research
Obesity is associated with a significant disease burden, but whether recognising as opposed to failing to recognise personal overweight is beneficial or detrimental to mental health is unclear. Here we examine the associations between perceived overweight ...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
In conclusion, leanness and exercise do not necessarily protect from OVX-induced weight gain. Exercise prevented weight gain in obese rats, but loss of SPA was the greatest contributor to post-OVX weight gain. Thus, understanding the mechanisms resulting in reduction in SPA after ovarian hormone loss is critical in the prevention of menopause-associated metabolic dysfunction.
Source: Medicine and Science in Sports and Exercise - Category: Sports Medicine Tags: BASIC SCIENCES Source Type: research
Publication date: January 2020Source: Epilepsy &Behavior, Volume 102Author(s): Anny Reyes, Sanam J. Lalani, Erik Kaestner, Kiera Hooper, Austin Chen, Anna Christina Macari, Brianna M. Paul, Bruce P. Hermann, Carrie R. McDonaldAbstractCerebrovascular risk factors (CVRFs) and comorbid cardiovascular and metabolic disease have been linked to accelerated cognitive aging and dementia in the general population; however, the contribution of these comorbidities to the risk of post anterior temporal lobectomy (ATL) memory decline has been unexamined. We explored the effects of CVRFs on postoperative verbal memory decline in a c...
Source: Epilepsy and Behavior - Category: Neurology Source Type: research
Conclusions: Although heterogeneity across cohorts may explain some medication utilization differences, ustekinumab was associated with lower discontinuation and greater persistence and adherence. PMID: 31714168 [PubMed - as supplied by publisher]
Source: Journal of Dermatological Treatment - Category: Dermatology Tags: J Dermatolog Treat Source Type: research
Conditions:   Rheumatoid Arthritis;   Psoriatic Arthritis;   Crohn's Disease;   Axial Spondyloarthritis;   Plaque Psoriasis Intervention:   Drug: Pharmacokinetics of certolizumab pegol Sponsor:   UCB Biopharma S.P.R.L. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Atopic Dermatitis Intervention:   Drug: Drug: SHR0302 Sponsor:   Reistone Biopharma Company Limited Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Atopic Dermatitis Interventions:   Drug: Etrasimod;   Drug: Etrasimod matching placebo Sponsor:   Arena Pharmaceuticals Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Obesity;   Sweeteners Interventions:   Dietary Supplement: Stevia;   Dietary Supplement: Glucose;   Dietary Supplement: Maltodextrin;   Dietary Supplement: Water Sponsors:   University of Manchester;   Cargill Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Publication date: Available online 13 November 2019Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Dr. Ivan D. Cardona, Dr. Erin E. Kempe, Dr. Christine Lary, Ms. Julia H. Ginder, Dr. Neal JainAbstractBackgroundStudies evaluating bathing frequency in pediatric atopic dermatitis (AD) are limited. Parents of children with AD often receive conflicting information, leading to frustration and confusion.ObjectiveTo evaluate efficacy of twice-daily, soaking baths, followed by immediate application of an occlusive moisturizer (i.e. soak-and-seal [SS]), versus twice-weekly SS baths, in the acute manage...
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research
More News: Cardiology | Cardiovascular | Dermatitis | Dermatology | Eating Disorders & Weight Management | Gallstones | Heart | Obesity | Psoriasis | Study